Shigeo Ohba

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Fluorescence Imaging

Top Venues

Medical molecular morphology

Journal of neuro-oncology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shigeo Ohba, Kazuhiro Murayama, Takao Teranishi, Masanobu Kumon, Shunsuke Nakae, Masao Yui, Kaori Yamamoto, Seiji Yamada, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose
Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma. Cancers 15 (3) (2023)
Shigeo Ohba, Kazuhiro Murayama, Takao Teranishi, Masanobu Kumon, Shunsuke Nakae, Masao Yui, Kaori Yamamoto, Seiji Yamada, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose
Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma. Cancers 15 (3) (2023)
Shigeo Ohba, Kei Yamashiro, Yuichi Hirose
Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells. Cancers 13 (11) (2021)
Joydeep Mukherjee, Ajay Pandita, Kamalakar Chatla, Tor-Christian Johannessen, Shigeo Ohba, Yongjian Tang, Cecilia L Dalle-Ore, Rolf Bjerkvig
A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells. Science translational medicine 13 (592) (2021)
Shigeo Ohba, Yuichi Hirose
L-asparaginase and 6-diazo-5-oxo-L-norleucine synergistically inhibit the growth of glioblastoma cells. Journal of neuro-oncology 146 (3) (2020)
Kiyonori Kuwahara, Shigeo Ohba, Shunsuke Nakae, Natsuki Hattori, Eriel Sandika Pareira, Seiji Yamada, Hikaru Sasaki, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose
Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis. Brain tumor pathology 36 (4) (2019)
Shigeo Ohba, Yuichi Hirose
Association between mutant IDHs and tumorigenesis in gliomas. Medical molecular morphology 51 (4) (2018)